Evidence map›Paper›PMID 36854551›Full record

ArticleSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi2023

[Interferon-related gene array in predicting the efficacy of interferon therapy in chronic hepatitis B].

Jiayi Wang, Jiajie Lu, Chen Zhou, Lingyao Du, Hong Tang

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jiayi WangCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, P. R. China.
Jiajie LuCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, P. R. China.
Chen ZhouWest China School of Medicine, Sichuan University, Chengdu 610041, P. R. China.
Lingyao DuCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, P. R. China.
Hong TangCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, P. R. China.
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to clarify host factors of IFN treatment in the treatment of chronic hepatitis B (CHB) patients by screening the differentially expressed genes of IFN pathway CHB patients with different response to interferon (IFN) therapy. Three cases were randomly selected in IFN-responding CHB patients (Rs), non-responding CHB patients (NRs) and healthy participants, respectively. The human type I IFN response RT

Indexed as

Hepatitis B, ChronicInterferonsOligonucleotide Array Sequence AnalysisHealthy VolunteersHumansImmunotherapyInterleukin-15Leukocytes, MononuclearNuclear ProteinsTreatment OutcomeInterferonsInterleukin-15Nuclear ProteinsPYHIN1 protein, humanChronic hepatitis BGene arrayInterferonsTreatment response

Identifiers

PMID36854551
PMCPMC9989755
OpenAlexW4322719216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.